Leana S. Wen's most recent trade in UroGen Pharma Ltd was a trade of 10,000 Stock Option (right ot buy) done . Disclosure was reported to the exchange on Aug. 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| UroGen Pharma Ltd | Leana S. Wen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2025 | 10,000 | 10,000 | - | - | Stock Option (right ot buy) | |
| UroGen Pharma Ltd | Leana S. Wen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2025 | 8,000 | 8,000 | - | - | Restricted Stock Unit | |
| Glaukos Corporation | Leana S. Wen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 3,149 | 3,149 | - | - | Stock Option (Right to Buy) | |
| Glaukos Corporation | Leana S. Wen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 2,108 | 20,816 (0%) | 0% | 0 | Common Stock | |
| Glaukos Corporation | Leana S. Wen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 461 | 18,708 (0%) | 0% | 0 | Common Stock | |
| UroGen Pharma Ltd | Leana S. Wen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2024 | 10,000 | 10,000 | - | - | Stock Option (right ot buy) | |
| Glaukos Corporation | Leana S. Wen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 1,716 | 18,247 (0%) | 0% | 0 | Common Stock | |
| Glaukos Corporation | Leana S. Wen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 1,246 | 1,246 | - | - | Stock Option (Right to Buy) | |
| Glaukos Corporation | Leana S. Wen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 3,230 | 16,531 (0%) | 0% | 0 | Common Stock | |
| Glaukos Corporation | Leana S. Wen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 1,572 | 13,301 (0%) | 0% | 0 | Common Stock | |
| Glaukos Corporation | Leana S. Wen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 1,572 | 13,301 (0%) | 0% | 0 | Common Stock | |
| UroGen Pharma Ltd | Leana S. Wen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Glaukos Corporation | Leana S. Wen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 4,364 | 11,729 (0%) | 0% | 0 | Common Stock | |
| Glaukos Corporation | Leana S. Wen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 1,455 | 7,365 (0%) | 0% | 0 | Common Stock | |
| Glaukos Corporation | Leana S. Wen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 2,382 | 5,910 (0%) | 0% | 0 | Common Stock | |
| Glaukos Corporation | Leana S. Wen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 3,079 | 3,079 (0%) | 0% | 0 | Common Stock | |
| Glaukos Corporation | Leana S. Wen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 449 | 3,528 (0%) | 0% | 0 | Common Stock |